Jim Simons’s Integra LifeSciences IART Stock Holding History

Jim Simons’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,760	Closed	-$183K	–	3442
2025 Q4	$183K	Buy	+14,760	New	+$196K	﹤0.01%	2904
2024 Q1	–	Sell	-103,560	Closed	-$4.51M	–	3863
2023 Q4	$4.51M	Buy	+103,560	New	+$4.08M	0.01%	1416
2023 Q3	–	Sell	-66,300	Closed	-$2.73M	–	3854
2023 Q2	$2.73M	Sell	66,300 -98,191	-60%	-$4.73M	﹤0.01%	1805
2023 Q1	$9.44M	Buy	164,491 +41,291	+34%	+$2.33M	0.01%	1110
2022 Q4	$6.91M	Sell	123,200 -207,573	-63%	-$10.6M	0.01%	1304
2022 Q3	$14M	Buy	330,773 +159,913	+94%	+$8.19M	0.02%	855
2022 Q2	$9.23M	Buy	170,860 +10,400	+6%	+$625K	0.01%	1152
2022 Q1	$10.3M	Buy	160,460 +120,600	+303%	+$7.94M	0.01%	1109
2021 Q4	$2.67M	Buy	39,860 +30,600	+330%	+$2.07M	﹤0.01%	1926
2021 Q3	$634K	Sell	9,260 -47,800	-84%	-$3.38M	﹤0.01%	2785
2021 Q2	$3.89M	Buy	+57,060	New	+$4.04M	﹤0.01%	1787
2020 Q4	–	Sell	-30,660	Closed	-$1.45M	–	3523
2020 Q3	$1.45M	Buy	+30,660	New	+$1.46M	﹤0.01%	2306
2020 Q2	–	Sell	-93,060	Closed	-$4.16M	–	3580
2020 Q1	$4.16M	Sell	93,060 -77,700	-46%	-$4.08M	﹤0.01%	1676
2019 Q4	$9.95M	Sell	170,760 -102,300	-37%	-$6.09M	0.01%	1453
2019 Q3	$16.4M	Buy	273,060 +180,300	+194%	+$10.7M	0.01%	1075
2019 Q2	$5.18M	Buy	+92,760	New	+$4.78M	﹤0.01%	1795
2019 Q1	–	Sell	-148,360	Closed	-$6.69M	–	3547
2018 Q4	$6.69M	Sell	148,360 -209,800	-59%	-$11.5M	0.01%	1555
2018 Q3	$23.6M	Buy	358,160 +303,000	+549%	+$18.8M	0.02%	831
2018 Q2	$3.55M	Sell	55,160 -235,340	-81%	-$14.6M	﹤0.01%	1976
2018 Q1	$16.1M	Sell	290,500 -115,300	-28%	-$6.04M	0.02%	1072
2017 Q4	$19.4M	Buy	405,800 +194,900	+92%	+$9.54M	0.02%	954
2017 Q3	$10.6M	Buy	210,900 +201,200	+2,074%	+$10.3M	0.01%	1289
2017 Q2	$529K	Sell	9,700 -163,960	-94%	-$7.83M	﹤0.01%	2749
2017 Q1	$7.32M	Buy	+173,660	New	+$7.42M	0.01%	1455
2016 Q4	–	Sell	-38,060	Closed	-$1.57M	–	3338
2016 Q3	$1.57M	Sell	38,060 -167,000	-81%	-$7M	﹤0.01%	2336
2016 Q2	$8.18M	Buy	205,060 +138,400	+208%	+$4.98M	0.02%	1271
2016 Q1	$2.25M	Sell	66,660 -36,000	-35%	-$1.12M	﹤0.01%	2150
2015 Q4	$3.48M	Sell	102,660 -7,200	-7%	-$225K	0.01%	1733
2015 Q3	$3.27M	Buy	109,860 +65,535	+148%	+$2.05M	0.01%	1670
2015 Q2	$1.22M	Sell	44,325 -113,057	-72%	-$3.01M	﹤0.01%	2343
2015 Q1	$3.97M	Buy	157,382 +144,171	+1,091%	+$3.41M	0.01%	1507
2014 Q4	$293K	Buy	+13,211	New	+$268K	﹤0.01%	2587
2014 Q3	–	Sell	-18,422	Closed	-$354K	–	2861
2014 Q2	$354K	Buy	+18,422	New	+$343K	﹤0.01%	2425

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jim Simons's IART Position: Q1 2026 in Review

Jim Simons sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 14,760 shares — an estimated $183K sold.

Jim Simons first reported a position in IART in Q2 2014 and held it in 33 quarters. The position peaked at $23.6M in Q3 2018. 202 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Jim Simons reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
Jim Simons sold 14,760 Integra LifeSciences shares in Q1 2026, an estimated $183K.
Jim Simons first reported a position in Integra LifeSciences in Q2 2014 and held it in 33 quarters.
Jim Simons's Integra LifeSciences position peaked at $23.6M in Q3 2018.
202 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.